Biotinylated-lipid bilayer coated mesoporous silica nanoparticles for improving the bioavailability and anti-leukaemia activity of Tanshinone IIA
- 29 January 2018
- journal article
- research article
- Published by Taylor & Francis in Artificial Cells, Nanomedicine, and Biotechnology
- Vol. 46 (sup1) , 578-587
Abstract
The oral bioavailability and anti-leukaemia activity of Tanshinone IIA (TanIIA) were enhanced by using biotinylated-lipid bilayer coated mesoporous silica nanoparticles (Bio-LB-MSNs) as a vehicle. The in vitro release of TanIIA from TanIIA@MSNs was significantly higher than that of the TanIIA powder (p < .05). The in vitro cellular uptake of TanIIA by Caco-2 was increased by loading drug into the Bio-LB-MSNs more than those of the compared nanovehicles without biotin modification. The apparent in situ permeability coefficient (Papp) of TanIIA@Bio-LB-MSNs showed nearly 2.5-, 1.6- and 1.3-fold improvement compared with the TanIIA powder, TanIIA@MSNs and TanIIA@LB-MSNs. Following oral administration of TanIIA@Bio-LB-MSNs in rats, the area under the plasma concentration–time curves (AUC) of TanIIA was 3.4-, 1.9- and 2.4-fold larger than those in the groups received a pure TanIIA powder, TanIIA@MSNs or TanIIA@LB-MSNs, indicating that drug bioavailability was enhanced by using MSNs as a vehicle, and further improved significantly through biotin modification. The in vitro anti-leukaemia activity of TanIIA was also enhanced after being loaded into nanoparticles and modification, with 50% inhibitive concentration (IC50) of NB4 cells at 6.5 μM for TanIIA@Bio-LB-MSN. In conclusion, Bio-LB-MSNs are a promising vehicle to improve the oral bioavailability and anti-leukaemia activity of the poorly water-soluble drug TanIIA.Keywords
Funding Information
- National Natural Science Foundation of China
This publication has 32 references indexed in Scilit:
- Enhancing biopharmaceutical performance of an anticancer drug by long chain PUFA based self-nanoemulsifying lipidic nanomicellar systemsEuropean Journal of Pharmaceutics and Biopharmaceutics, 2017
- BRM/SMARCA2 promotes the proliferation and chemoresistance of pancreatic cancer cells by targeting JAK2/STAT3 signalingCancer Letters, 2017
- Cellular uptake of glucoheptoamidated poly(amidoamine) PAMAM G3 dendrimer with amide-conjugated biotin, a potential carrier of anticancer drugsBioorganic & Medicinal Chemistry, 2017
- Targeted delivery of quercetin loaded mesoporous silica nanoparticles to the breast cancer cellsBiochimica et Biophysica Acta (BBA) - General Subjects, 2016
- Colloidal mesoporous silica nanoparticles enhance the biological activity of resveratrolColloids and Surfaces B: Biointerfaces, 2016
- Protocells: Modular Mesoporous Silica Nanoparticle‐Supported Lipid Bilayers for Drug DeliverySmall, 2016
- Tanshinone IIA inhibits acute promyelocytic leukemia cell proliferation and induces their apoptosis in vivoBlood Cells, Molecules, and Diseases, 2016
- An anticancer drug delivery system based on surfactant-templated mesoporous silica nanoparticlesBiomaterials, 2010
- Increasing the oral bioavailability of the poorly water soluble drug itraconazole with ordered mesoporous silicaEuropean Journal of Pharmaceutics and Biopharmaceutics, 2008
- Studies on pore systems in catalysts V. The t methodJournal of Catalysis, 1965